Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Jul 30, 2026
- Incorporated
- Delaware
- Filings on record
- 739 filings
- On EDGAR
- CIK 1631574
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 57
News 8 of 160
Prospectuses and Registrations 8 of 62
- POS AM Post-effective amendment to a registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
- S-8 POS Post-effective amendment to an employee plan registration Aug 10, 2026
Proxies 8 of 15
- DEF 14A Proxy statement for a shareholder vote Oct 14, 2026
- DEF 14A Proxy statement for a shareholder vote May 7, 2026
- DEFA14A Extra proxy material Apr 21, 2026
- PRE 14A Preliminary proxy statement Apr 15, 2026
- DEFA14A Extra proxy material Apr 15, 2026
- DEF 14A Proxy statement for a shareholder vote Jun 23, 2025
- DEF 14A Proxy statement for a shareholder vote Jun 21, 2024
- DEF 14A Proxy statement for a shareholder vote Jun 26, 2023
Ownership 8 of 401
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
Other 8 of 44
Everything here comes from Wave Life Sciences, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.